Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Fogazza

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta. Bioenergetics|February 1, 2018
Eight human OPA1 isoforms, long and short: What are they for?Valentina Del Dotto, Mario Fogazza, Valerio Carelli, et al.
Pharmacological Research|February 19, 2018
OPA1: How much do we know to approach therapy?Valentina Del Dotto, Mario Fogazza, Guy Lenaers, et al.
Human Molecular Genetics|November 24, 2020
Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutationsSerena J Aleo, Valentina Del Dotto, Mario Fogazza, et al.
Cell Reports|June 22, 2017
OPA1 Isoforms in the Hierarchical Organization of Mitochondrial FunctionsValentina Del Dotto, Prashant Mishra, Sara Vidoni, et al.
Human Molecular Genetics|March 24, 2020
Metabolomics hallmarks OPA1 variants correlating with their in vitro phenotype and predicting clinical severityJuan Manuel Chao de la Barca, Mario Fogazza, Michela Rugolo, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 9, 2018
Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell modelsValentina Del Dotto, Mario Fogazza, Francesco Musiani, et al.
Clinical Epigenetics|December 22, 2023
In-silico guided chemical exploration of KDM4A fragments hitsJessica Lombino, Rosario Vallone, Maura Cimino, et al.
Frontiers in Pharmacology|July 25, 2024
Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamilyDaniela Digles, Alvaro Ingles-Prieto, Vojtech Dvorak, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta. Bioenergetics|February 1, 2018
Eight human OPA1 isoforms, long and short: What are they for?Valentina Del Dotto, Mario Fogazza, Valerio Carelli, et al.
Pharmacological Research|February 19, 2018
OPA1: How much do we know to approach therapy?Valentina Del Dotto, Mario Fogazza, Guy Lenaers, et al.
Human Molecular Genetics|November 24, 2020
Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutationsSerena J Aleo, Valentina Del Dotto, Mario Fogazza, et al.
Cell Reports|June 22, 2017
OPA1 Isoforms in the Hierarchical Organization of Mitochondrial FunctionsValentina Del Dotto, Prashant Mishra, Sara Vidoni, et al.
Human Molecular Genetics|March 24, 2020
Metabolomics hallmarks OPA1 variants correlating with their in vitro phenotype and predicting clinical severityJuan Manuel Chao de la Barca, Mario Fogazza, Michela Rugolo, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 9, 2018
Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell modelsValentina Del Dotto, Mario Fogazza, Francesco Musiani, et al.
Clinical Epigenetics|December 22, 2023
In-silico guided chemical exploration of KDM4A fragments hitsJessica Lombino, Rosario Vallone, Maura Cimino, et al.
Frontiers in Pharmacology|July 25, 2024
Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamilyDaniela Digles, Alvaro Ingles-Prieto, Vojtech Dvorak, et al.
Pageof 1